XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2022 $ 30 $ 229 $ 172,471 $ 316,279 $ 15,761 $ 504,770
Increase (decrease) in shareholders' equity            
Net Income (Loss)       (5,993)   (5,993)
Stock Repurchase   (3) (5,006)     (5,009)
Vested Restricted Stock and Performance Shares   1 (1,029)     (1,028)
Exercise of Stock Options and Stock Issuance to Directors     241     241
Stock Issuance, Net of Equity Issuance Costs     (71)     (71)
Stock-Based Compensation Expense     830     830
Preferred Stock Dividends Declared for the Period       (1,195)   (1,195)
Common Stock Dividends Declared for the Period       (9,025)   (9,025)
Other Comprehensive Income (Loss)         (4,891) (4,891)
Balance at Mar. 31, 2023 30 227 167,436 300,066 10,870 478,629
Balance at Dec. 31, 2022 30 229 172,471 316,279 15,761 504,770
Balance at Dec. 31, 2023 30 226 168,435 281,944 6,891 457,526
Increase (decrease) in shareholders' equity            
Net Income (Loss)       5,842   5,842
Stock Repurchase     (664)     (664)
Vested Restricted Stock and Performance Shares   1 (1,275)     (1,274)
Exercise of Stock Options and Stock Issuance to Directors     380     380
Stock Issuance, Net of Equity Issuance Costs   2 2,062     2,064
Stock-Based Compensation Expense     986     986
Preferred Stock Dividends Declared for the Period       (1,187)   (1,187)
Common Stock Dividends Declared for the Period       (8,945)   (8,945)
Other Comprehensive Income (Loss)         7,513 7,513
Balance at Mar. 31, 2024 $ 30 $ 229 $ 169,924 $ 277,654 $ 14,404 $ 462,241